ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling
Jane T Seto, Kate GR Quinlan, Monkol Lek, Xi Fiona Zheng, Fleur Garton, Daniel G MacArthur, Marshall W Hogarth, Peter J Houweling, Paul Gregorevic, Nigel Turner, Gregory J Cooney, Nan Yang, Kathryn N North
Journal of Clinical Investigation | AMER SOC CLINICAL INVESTIGATION INC | Published : 2013
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by Early Career Fellowships from the NHMRC of Australia
Awarded by Dora Lush Biomedical Scholarship from the NHMRC of Australia
This project was funded in part by a grant from the National Health and Medical Research Council of Australia (NHMRC) (1002033). J.T. Seto and K.G.R. Quinlan are supported by Early Career Fellowships from the NHMRC of Australia (1036656 and 0511981). M. Lek and F. Garton are supported by Australian Postgraduate Awards. X.F. Zheng is supported by a Dora Lush Biomedical Scholarship from the NHMRC of Australia (1038991). N. Turner is supported by a Future Fellowship from the Australian Research Council. G.J. Cooney is supported by a Research Fellowship from the NHMRC of Australia. P. Gregorevic is supported by a Senior Research Fellowship sponsored by Pfizer Australia. The Baker IDI Heart and Diabetes Institute is supported in part by the Operational Infrastructure Support Program of the Victorian Government. We thank Hongwei Qian for the manufacture of the rAAV vectors.